David A. Siegel Meridian Bioscience Inc Transaction History

Two Sigma Advisers, LP

$43.8 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$31.15 - $33.39 $6.76 Million - $7.24 Million	216,900 Added 443.56%	265,800 $8.83 Million
Q3 2022 Nov 14, 2022	SELL	$30.9 - $33.55 $2.41 Million - $2.62 Million	-78,100 Reduced 61.5%	48,900 $1.54 Million
Q2 2022 Aug 15, 2022	BUY	$23.75 - $31.69 $1.07 Million - $1.43 Million	45,100 Added 55.07%	127,000 $3.86 Million
Q1 2022 May 16, 2022	BUY	$19.97 - $26.94 $195,706 - $264,012	9,800 Added 13.59%	81,900 $2.13 Million
Q4 2021 Feb 14, 2022	BUY	$17.46 - $21.61 $123,966 - $153,431	7,100 Added 10.92%	72,100 $1.47 Million
Q3 2021 Nov 15, 2021	SELL	$17.35 - $22.5 $293,215 - $380,250	-16,900 Reduced 20.63%	65,000 $1.25 Million
Q2 2021 Aug 16, 2021	SELL	$18.01 - $28.32 $875,286 - $1.38 Million	-48,600 Reduced 37.24%	81,900 $1.82 Million
Q1 2021 May 17, 2021	BUY	$19.76 - $29.89 $302,328 - $457,317	15,300 Added 13.28%	130,500 $3.43 Million
Q4 2020 Feb 16, 2021	SELL	$15.73 - $21.66 $2.31 Million - $3.18 Million	-146,800 Reduced 56.03%	115,200 $2.15 Million
Q3 2020 Nov 16, 2020	SELL	$13.54 - $26.41 $1.67 Million - $3.25 Million	-123,200 Reduced 31.98%	262,000 $4.45 Million
Q2 2020 Aug 14, 2020	BUY	$7.84 - $23.29 $1.14 Million - $3.4 Million	145,900 Added 60.97%	385,200 $8.97 Million
Q1 2020 May 15, 2020	BUY	$5.57 - $11.5 $750,836 - $1.55 Million	134,800 Added 129.0%	239,300 $2.01 Million
Q4 2019 Feb 14, 2020	BUY	$7.9 - $10.14 $408,232 - $523,984	51,675 Added 97.82%	104,500 $1.02 Million
Q3 2019 Nov 14, 2019	SELL	$9.17 - $12.01 $540,113 - $707,389	-58,900 Reduced 52.72%	52,825 $501,000
Q2 2019 Aug 14, 2019	SELL	$10.88 - $17.6 $416,867 - $674,344	-38,315 Reduced 25.54%	111,725 $1.33 Million
Q1 2019 May 15, 2019	SELL	$15.51 - $17.61 $746,031 - $847,041	-48,100 Reduced 24.28%	150,040 $2.64 Million
Q4 2018 Feb 14, 2019	SELL	$14.52 - $19.72 $98,750 - $134,115	-6,801 Reduced 3.32%	198,140 $3.44 Million
Q3 2018 Nov 14, 2018	SELL	$14.85 - $16.35 $803,385 - $884,535	-54,100 Reduced 20.88%	204,941 $3.05 Million
Q2 2018 Aug 14, 2018	BUY	$13.8 - $16.8 $440,220 - $535,920	31,900 Added 14.04%	259,041 $4.12 Million
Q1 2018 May 15, 2018	SELL	$13.8 - $16.2 $91,080 - $106,920	-6,600 Reduced 2.82%	227,141 $3.23 Million
Q4 2017 Feb 14, 2018	BUY	$13.55 - $15.8 $79,945 - $93,220	5,900 Added 2.59%	233,741 $3.27 Million
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $3.06 Million - $3.27 Million	227,841	227,841 $3.26 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account